Trump proposes NIH budget cut, raising questions about future medical breakthroughs
President Donald Trump’s fiscal 2027 budget plan would lower NIH funding from about $46.5 billion to roughly $41.5 billion, prompting concerns over the impact on upcoming medicines.
In the fiscal 2027 budget, President Donald Trump seeks to reduce the NIH’s overall appropriation from roughly $46.5 billion to $41.5 billion, a decrease of about $5 billion. The National Cancer Institute would see a marginal increase, staying near $7.35 billion, whereas the National Center for Advancing Translational Sciences would see its budget fall from about $942 million to $873 million. The proposal highlights the difficulty of aligning budget lines with the interdisciplinary nature of biomedical research, where breakthroughs in one field often rely on advances in others.
Critics argue that such cuts could weaken the United States’ capacity to develop future therapies and cede scientific leadership to rivals like China. They suggest preserving core capabilities—basic biology, shared data resources, translational networks, and training programs—that are unlikely to be funded privately and would be hard to rebuild if lost.
Why it matters
Reduced NIH funding could limit the research that underpins tomorrow’s treatments and affect U.S. scientific competitiveness.
In this story
